Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

Fig. 2

Phenotypic characterization of genetically-modified NK-92MI cells. Surface expression levels of various NK-92MI activation receptors were measured by flow cytometry. There was no significant difference between anti-CEA-CAR NK-92MI and parental NK-92MI cells in terms of (a) NKG2D, (b) CD56, and (c) CD45. Black line represents transfected anti-CEA-CAR NK-92MI cells. Grey line represents non-transfected NK-92MI cells. Dotted lines represent cells stained with isotype control

Back to article page